TL;DR
This study uses molecular dynamics simulations to reveal how graphene oxide (GO) inhibits the enzyme α-chymotrypsin (ChT) by deforming its active site. This work provides crucial mechanistic insights for designing novel enzyme inhibitors based on GO.
What Problem Does This Paper Address?
Enzymes are fundamental to countless biological processes and are key targets for drug development. While various molecules can inhibit enzyme activity, there's a constant need for new, effective inhibitors. Graphene oxide (GO) has emerged as a promising material with broad applications, and recent studies have shown it to be a potent inhibitor of α-chymotrypsin (ChT). However, the precise molecular mechanisms behind this inhibition were unclear. Understanding how GO interacts with enzymes at an atomic level is crucial for harnessing its potential in enzyme engineering and developing targeted therapies. This paper aims to elucidate this interaction mechanism.
Methods
The researchers employed Molecular Dynamics (MD) simulations to investigate the interactions between ChT and both graphene and graphene oxide (GO).
- MD Simulations: These simulations model the dynamic behavior of atoms and molecules over time, allowing researchers to observe how proteins and materials interact. They ran 100 ns simulations to capture the adsorption process.
- Protein Preparation: The crystal structures of ChT and trypsin were obtained from the Protein Data Bank and prepared using software like Discovery Studio. Protonation states of key residues were determined to mimic physiological conditions.
- Graphene/GO Model: Graphene and GO models were constructed with specific sizes and functionalization (epoxy, hydroxyl, and carboxyl groups for GO) to represent realistic scenarios.
- Docking Studies: To assess the impact of GO/graphene adsorption on the enzyme's active site and its ability to bind ligands, CDocker, a molecular docking program, was used. Proflavine, a known ligand, was docked into different ChT conformations.
Datasets
The study utilized the crystal structures of α-chymotrypsin (ChT) and trypsin obtained from the Protein Data Bank (PDB entries: 4CHA and 1TRN, respectively). No new datasets or benchmarks were introduced.
Key Insights and Ideas
- Differential Adsorption: ChT adsorbs onto both graphene and GO, but the nature of the interaction differs significantly.
- GO's Potent Inhibition Mechanism: GO's inhibition of ChT is primarily driven by strong interactions with cationic and hydrophobic residues of ChT, leading to a substantial deformation of ChT's active site.
- Graphene's Milder Effect: Graphene, lacking the oxygen-containing functional groups of GO, interacts with ChT through hydrophobic forces, causing only minor alterations to the active site.
- The α-helix as an Anchor: A specific α-helix in ChT acts as a crucial "anchor" that facilitates its strong adsorption onto the GO surface.
- S1 Specificity Pocket Deformation: The deformation of the S1 specificity pocket in ChT upon GO adsorption is the key to its inhibition, making it unavailable for ligand binding.
- Trypsin as a Validation: Similar interactions and inhibition mechanisms were observed for trypsin, another serine protease, suggesting this GO-enzyme interaction principle is broadly applicable to this class of enzymes.
Key Results
- Adsorption: ChT was observed to adsorb onto both graphene and GO surfaces during 100 ns MD simulations. The average minimum distance between GO and ChT was ~0.85 Å, while for graphene, it was ~1.86 Å.
- Interaction Modes:
- Graphene: ChT adsorbed primarily through hydrophobic interactions, with residues like Ile6, Val9, Val23, Pro24, and Ala149 contributing. The active site was only slightly affected.
- GO: ChT adsorbed via strong interactions with cationic and hydrophilic residues, particularly through its α-helix. This led to significant deformation of the S1 specificity pocket.
- Active Site Deformation:
- Graphene: The volume of the S1 active site changed from 146.1 ų (crystal structure) to 130.0 ų (average from MD).
- GO: The volume of the S1 active site decreased significantly to 75.8 ų (average from MD).
- Ligand Docking: Docking studies with proflavine showed that while the ligand could bind effectively to ChT on graphene (similar to the crystal structure), binding to GO-adsorbed ChT was severely hindered, with docking scores indicating very weak interactions.
Limitations and Future Work
- His57 Protonation State: The study explored both protonated and deprotonated His57 states, finding that this did not significantly affect the interaction between ChT and GO/graphene, as His57 was located far from the interface. However, this might be a simplification for other enzyme-GO interactions.
- GO Functionalization: The GO model used was "not significantly oxidized" (C1001(OH)1), representing a specific level of oxidation. Varying degrees of oxidation could lead to different interaction profiles.
- Future Directions: The authors suggest that these findings provide guidelines for designing more efficient artificial inhibitors by systematically modifying GO functionality. Further exploration of GO's interaction with other complex proteins is also implied.
Summary updated